Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)-Reference-Cited by-同舟云学术

Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)

Published:2007 Issue:2 Volume:57 Page:310-317
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Devauchelle-Pensec Valérie,Pennec Yvon,Morvan Johanne,Pers Jacques-Olivier,Daridon Capucine,Jousse-Joulin Sandrine,Roudaut Anne,Jamin Christophe,Renaudineau Yves,Roué Isabelle Quintin,Cochener Béatrice,Youinou Pierre,Saraux Alain

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference44 articles.

1. Prevalence of Sjogren's syndrome in a closed rural community

2. Sjogren's Syndrome

3. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome

4. BAFF-induced changes in B cell antigen receptor–containing lipid rafts in Sjögren's syndrome

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine in Sjögren's disease;The Lancet Rheumatology;2024-09

2. Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease;Medicina Clínica;2024-08

3. Primary Sjögren’s syndrome: new perspectives on salivary gland epithelial cells;European Journal of Medical Research;2024-07-17

4. Update on the pathophysiology and treatment of primary Sjögren syndrome;Nature Reviews Rheumatology;2024-07-09

5. Salivary gland biopsy as a prognostic tool in Sjögren’s syndrome;Expert Review of Clinical Immunology;2024-06-24